- Home
- PANW vs MDT Comparison
PANW vs MDT Comparison
Compare PANW & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANW
- MDT
- Stock Information
- Founded
- PANW 2005
- MDT 1949
- Country
- PANW United States
- MDT Ireland
- Employees
- PANW N/A
- MDT N/A
- Industry
- PANW Computer peripheral equipment
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PANW Technology
- MDT Health Care
- Exchange
- PANW Nasdaq
- MDT Nasdaq
- Market Cap
- PANW 124.9B
- MDT 109.2B
- IPO Year
- PANW 2012
- MDT N/A
- Fundamental
- Price
- PANW $194.86
- MDT $83.76
- Analyst Decision
- PANW Buy
- MDT Hold
- Analyst Count
- PANW 46
- MDT 16
- Target Price
- PANW $207.22
- MDT $94.73
- AVG Volume (30 Days)
- PANW 5.8M
- MDT 8.2M
- Earning Date
- PANW 05-20-2025
- MDT 05-21-2025
- Dividend Yield
- PANW N/A
- MDT 3.39%
- EPS Growth
- PANW N/A
- MDT 30.80
- EPS
- PANW 1.74
- MDT 3.61
- Revenue
- PANW $8,874,700,000.00
- MDT $33,537,000,000.00
- Revenue This Year
- PANW $16.46
- MDT $5.38
- Revenue Next Year
- PANW $14.87
- MDT $5.08
- P/E Ratio
- PANW $111.98
- MDT $23.20
- Revenue Growth
- PANW 13.90
- MDT 3.62
- 52 Week Low
- PANW $142.01
- MDT $75.96
- 52 Week High
- PANW $208.39
- MDT $96.25
- Technical
- Relative Strength Index (RSI)
- PANW 60.94
- MDT 49.66
- Support Level
- PANW $182.89
- MDT $79.93
- Resistance Level
- PANW $189.84
- MDT $88.28
- Average True Range (ATR)
- PANW 4.11
- MDT 1.51
- MACD
- PANW -0.26
- MDT -0.06
- Stochastic Oscillator
- PANW 96.66
- MDT 45.87
About PANW Palo Alto Networks Inc.
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three fourths of the Global 2000.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.